Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Luger

Showing results (21-30 of 311) with videos related to

Pageof 32
Sort By:
Haematologica|July 29, 2021
Dose intensity for induction in acute myeloid leukemia: what, when, and for whom?Shannon R McCurdy, Selina M Luger
Haematologica|September 1, 2025
A CHIP off the old (MDS) blockSelina M Luger, Bryan T Ciccarelli
Oncology (Williston Park, N.Y.)|June 7, 2005
The role of hematopoietic stem cell transplantation in myelodysplastic syndromeJames E Thompson, Selina M Luger
Current Opinion in Hematology|February 9, 2012
Beyond morphology: minimal residual disease detection in acute myeloid leukemiaCourtney D DiNardo, Selina M Luger
Notfall & Rettungsmedizin|September 9, 2017
Telephone-assisted CPR: A literature reviewM Maier, M Luger, M Baubin
American Journal of Hematology|February 6, 2009
Update on the therapy for myelodysplastic syndromeMargaret T Kasner, Selina M Luger
Seminars in Hematology|March 31, 2019
Maintenance therapy in acute myeloid leukemia: What is the future?Christine M McMahon, Selina M Luger
Current Hematologic Malignancy Reports|March 19, 2019
Relapsed T Cell ALL: Current Approaches and New DirectionsChristine M McMahon, Selina M Luger
Missouri Medicine|October 1, 1984
Primary pulmonary leiomyosarcoma with digital clubbing and pleural effusion. Case reportP M Passamonte, A M Luger
Bone Marrow Transplantation|April 25, 2006
Autologous stem cell transplant in ALL: who should we be transplanting in first remission?A R Mato, S M Luger
Pageof 32

Showing results (21-30 of 311) with videos related to

Sort By:
Pageof 32
Haematologica|July 29, 2021
Dose intensity for induction in acute myeloid leukemia: what, when, and for whom?Shannon R McCurdy, Selina M Luger
Haematologica|September 1, 2025
A CHIP off the old (MDS) blockSelina M Luger, Bryan T Ciccarelli
Oncology (Williston Park, N.Y.)|June 7, 2005
The role of hematopoietic stem cell transplantation in myelodysplastic syndromeJames E Thompson, Selina M Luger
Current Opinion in Hematology|February 9, 2012
Beyond morphology: minimal residual disease detection in acute myeloid leukemiaCourtney D DiNardo, Selina M Luger
Notfall & Rettungsmedizin|September 9, 2017
Telephone-assisted CPR: A literature reviewM Maier, M Luger, M Baubin
American Journal of Hematology|February 6, 2009
Update on the therapy for myelodysplastic syndromeMargaret T Kasner, Selina M Luger
Seminars in Hematology|March 31, 2019
Maintenance therapy in acute myeloid leukemia: What is the future?Christine M McMahon, Selina M Luger
Current Hematologic Malignancy Reports|March 19, 2019
Relapsed T Cell ALL: Current Approaches and New DirectionsChristine M McMahon, Selina M Luger
Missouri Medicine|October 1, 1984
Primary pulmonary leiomyosarcoma with digital clubbing and pleural effusion. Case reportP M Passamonte, A M Luger
Bone Marrow Transplantation|April 25, 2006
Autologous stem cell transplant in ALL: who should we be transplanting in first remission?A R Mato, S M Luger
Pageof 32